Methacrylic Acid

Methacrylic Acid

SCHEMBL59948

C=C(C)C(=O)O.O=C(O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Methacrylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.50
FFAR3 O14843 1/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
ALDH1A1 P00352 3/20 0.42
CA1 P00915 3/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
LMNA P02545 3/20 0.39
HSD17B10 Q99714 1/20 0.37
TSHR P16473 2/20 0.36
THPO P40225 1/20 0.36
TGFBR1 P36897 1/20 0.33
ALOX15 P16050 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
KDM4E B2RXH2 1/20 0.32
TET2 Q6N021 1/20 0.32
LDHA P00338 1/20 0.31
LDHB P07195 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL1723751 1.00 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL11058354 0.96 TDP1 (0.47) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL11058360 0.96 TDP1 (0.47) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL3207375 0.96 TDP1 (0.47) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL28292654 0.96 TDP1 (0.47) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL15043 0.96 TDP1 (0.53) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL15005463 0.96 TDP1 (0.53) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL11235035 0.96 TDP1 (0.53) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL491341 0.96 TDP1 (0.53) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL182989 0.96 TDP1 (0.53) TDP1FFAR3LCKFYNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 424 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240198582-A1 HYBRID RESIN COMPOSITION FOR THE 3D-PRINTING OF OBJECTS CUBICURE GMBH (AT) 2024-06-20 US claimed
US-11987658-B2 Curable resin composition and method of manufacturing article CANON KABUSHIKI KAISHA (JP) 2024-05-21 US claimed
EP-3802695-B1 STRETCHABLE SOLID-STATE ELECTROACTIVE POLYMER ACTUATORS BIOASTRA TECH INC (CA) 2023-07-05 EP claimed
US-20220282013-A1 CURABLE RESIN COMPOSITION AND METHOD OF MANUFACTURING ARTICLE CANON KABUSHIKI KAISHA (JP) 2022-09-08 US claimed
EP-2669085-B1 DECORATIVE SHEET, AND DECORATIVE RESIN-MOLDED ARTICLE EMPLOYING SAME DAINIPPON PRINTING CO LTD (JP) 2019-08-21 EP claimed
US-10273258-B2 Process for the preparation of acylphosphanes ETH ZUERICH (CH) 2019-04-30 US claimed
US-10265895-B2 Decorative sheet for three-dimensional molding and method for producing same, and decorative molded article using decorative sheet and method for producing same DAI NIPPON PRINTING CO., LTD. (JP) 2019-04-23 US claimed
US-20180002357-A1 PROCESS FOR THE PREPARATION OF ACYLPHOSPHANES ETH ZUERICH (CH) 2018-01-04 US claimed
EP-2689929-B1 DECORATIVE SHEET FOR THREE-DIMENSIONAL MOLDING AND METHOD FOR PRODUCING SAME, AND DECORATIVE MOLDED ARTICLE USING DECORATIVE SHEET AND METHOD FOR PRODUCING SAME DAINIPPON PRINTING CO LTD (JP) 2017-09-13 EP claimed
US-9605120-B2 Decorative sheet, and decorative resin-molded article employing same DAI NIPPON PRINTING CO., LTD. (JP) 2017-03-28 US claimed
WO-2007054289-A2 AQUEOUS POWDER DISPERSION, WHICH CAN BE CURED BY RADICAL POLYMERIZATION, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE BASF COATINGS AG (DE) 2007-05-18 WO claimed
WO-2007054288-A1 REPAIR FILM AND USE THEREOF BASF COATINGS AG (DE) 2007-05-18 WO claimed
WO-2005090494-A1 CER COMPOUNDS USED AS INITIATORS FOR THERMAL HARDENING BASF AKTIENGESELLSCHAFT (DE) 2005-09-29 WO claimed
EP-0965620-B1 Weather resistant carbonate acrylate radiation-curable coating compositions BASF AG (DE) 2003-04-23 EP claimed
EP-0951496-B1 ALKYD AND ARALKYD DERIVATIVES OF PHENOLIC POLYMERS GEORGIA PACIFIC RESINS (US) 2001-12-19 EP claimed
EP-0965620-A1 Weather resistant carbonate acrylate radiation-curable coating compositions BASF AKTIENGESELLSCHAFT (DE) 1999-12-22 EP claimed
EP-0424219-B1 Polycarbonate-polyol composition and polycarbonate (meth) acrylate compositions and urethane (meth) acrylate compositions prepared therefrom DAICEL CHEM (JP) 1996-05-08 EP claimed
US-5143997-A Photo-curable or electron-beam curable coatings DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1992-09-01 US claimed
EP-0424219-A2 Polycarbonate-polyol composition and polycarbonate (meth) acrylate compositions and urethane (meth) acrylate compositions prepared therefrom DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1991-04-24 EP claimed
EP-0106110-A1 Process for preparing copolymers of monoethylenically unsaturated mono- and dicarboxylic acids BASF Aktiengesellschaft (DE) 1984-04-25 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10273258-B2 Process for the preparation of acylphosphanes AGPAT5, AGPAT2, PHOSPHO1 TDP1 3637/4885FFAR3 2651/4885LCK 2615/4885
US-20180002357-A1 PROCESS FOR THE PREPARATION OF ACYLPHOSPHANES AGPAT5, AGPAT2, PHOSPHO1 TDP1 3637/4885FFAR3 2651/4885LCK 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.